268 related articles for article (PubMed ID: 37204726)
21. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
McGonagle D; De Marco G; Bridgewood C
J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
[TBL] [Abstract][Full Text] [Related]
22. Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT/TTS.
Favaloro EJ; Pasalic L; Lippi G
Antibodies (Basel); 2022 Jan; 11(1):. PubMed ID: 35225866
[TBL] [Abstract][Full Text] [Related]
23. Laboratory testing for VITT antibodies.
Warkentin TE; Greinacher A
Semin Hematol; 2022 Apr; 59(2):80-88. PubMed ID: 35512905
[TBL] [Abstract][Full Text] [Related]
24. Potential mechanisms of vaccine-induced thrombosis.
Marietta M; Coluccio V; Luppi M
Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia.
Warkentin TE; Greinacher A
Thromb Res; 2021 Aug; 204():40-51. PubMed ID: 34144250
[TBL] [Abstract][Full Text] [Related]
26. Platelet-activating anti-PF4 disorders: An overview.
Warkentin TE
Semin Hematol; 2022 Apr; 59(2):59-71. PubMed ID: 35512902
[TBL] [Abstract][Full Text] [Related]
27. Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.
Huynh A; Kelton JG; Arnold DM; Daka M; Nazy I
Nature; 2021 Aug; 596(7873):565-569. PubMed ID: 34233346
[TBL] [Abstract][Full Text] [Related]
28. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.
Reilly-Stitt C; Kitchen S; Jennings I; Horner K; Jones R; Makris M; Walker ID
J Thromb Haemost; 2021 Sep; 19(9):2263-2267. PubMed ID: 34227230
[TBL] [Abstract][Full Text] [Related]
29. The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia.
Singh A; Toma F; Uzun G; Wagner TR; Pelzl L; Zlamal J; Freytag V; Weich K; Nowak-Harnau S; Rothbauer U; Althaus K; Bakchoul T
Blood; 2022 Jun; 139(23):3430-3438. PubMed ID: 35679071
[TBL] [Abstract][Full Text] [Related]
30. Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.
Schönborn L; Thiele T; Kaderali L; Günther A; Hoffmann T; Seck SE; Selleng K; Greinacher A
Blood; 2022 Mar; 139(12):1903-1907. PubMed ID: 35113987
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
[TBL] [Abstract][Full Text] [Related]
32. Multiple Electrode Aggregometry (Multiplate): Functional Assay for Vaccine-Induced (Immune) Thrombotic Thrombocytopenia (VITT).
Kong Y; Kershaw G; Fu YKS; Passam F
Methods Mol Biol; 2023; 2663():429-440. PubMed ID: 37204728
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of laboratory assays for anti-platelet factor 4 antibodies after ChAdOx1 nCOV-19 vaccination.
Platton S; Bartlett A; MacCallum P; Makris M; McDonald V; Singh D; Scully M; Pavord S
J Thromb Haemost; 2021 Aug; 19(8):2007-2013. PubMed ID: 33973336
[TBL] [Abstract][Full Text] [Related]
34. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis (VITT): Results from a NEQAS, ECAT and SSC collaborative exercise in 385 centers worldwide.
Reilly-Stitt C; Jennings I; Kitchen S; Makris M; Meijer P; de Maat M; Scully M; Bakchoul T; Walker ID
J Thromb Haemost; 2022 Aug; 20(8):1875-1879. PubMed ID: 35603519
[TBL] [Abstract][Full Text] [Related]
35. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
[TBL] [Abstract][Full Text] [Related]
36. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
[TBL] [Abstract][Full Text] [Related]
37. Vaccine-induced immune thrombotic thrombocytopenia.
Kanack AJ; Padmanabhan A
Best Pract Res Clin Haematol; 2022 Sep; 35(3):101381. PubMed ID: 36494147
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Performance of a Particle Gel Immunoassay in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Uzun G; Althaus K; Hammer S; Wanner Y; Nowak-Harnau S; Enkel S; Bakchoul T
Hamostaseologie; 2023 Feb; 43(1):22-27. PubMed ID: 36807823
[TBL] [Abstract][Full Text] [Related]
39. Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity.
Greinacher A; Warkentin TE
Int J Lab Hematol; 2023 Jun; 45 Suppl 2():11-22. PubMed ID: 37150909
[TBL] [Abstract][Full Text] [Related]
40. Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands.
Meier RT; Porcelijn L; Hofstede-van Egmond S; Henskens YMC; Coutinho JM; Kruip MJHA; Stroobants AK; Zwaginga JJ; van der Bom JG; van der Schoot CE; de Haas M; Kapur R
Vox Sang; 2024 Apr; ():. PubMed ID: 38597072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
